Novel neural crest system developed in zebrafish
3/04/2014
Researchers at the Massachusetts General Hospital (MGH)/Harvard Medical School, Drs. Beste Kinikoglu and Yawei Kong, led by Dr. Eric C. Liao, cultured and characterized for the first time multipotent neural crest cells isolated from zebrafish embryos. This important study is reported in the journal Experimental Biology and Medicine.
Possible new target identified for future brain cancer drugs
3/04/2014
A molecule in cells that shuts down the expression of genes might be a promising target for new drugs designed to treat the most frequent and lethal form of brain cancer, according to a new study by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James).
Experts express concern over nanosilver found in everyday items that may be harmful to health
3/04/2014
Endocrine disrupters are not the only worrying chemicals that ordinary consumers are exposed to in everyday life. Also nanoparticles of silver, found in e.g. dietary supplements, cosmetics and food packaging, now worry scientists. A new study from the University of Southern Denmark shows that nano-silver can penetrate our cells and cause damage.
Mechanisms cancer cells use to establish metastatic brain tumors
3/04/2014
New research from Memorial Sloan Kettering provides fresh insight into the biologic mechanisms that individual cancer cells use to metastasize to the brain. Published in the journal Cell, the study found that tumor cells that reach the brain - and successfully grow into new tumors - hug capillaries and express specific proteins that overcome the brain's natural defense against metastatic invasion.
Researchers making treatment of rare blood disorder more affordable and effective
3/04/2014
A University of Pennsylvania research team has defined a possible new way to fight a disease that is currently treatable only with the most expensive drug available for sale in the United States.
How enzyme functions correlate with prostate cancer progression could lead to new treatments
3/04/2014
A University of Houston (UH) scientist and his team are working to develop the next generation of prostate cancer therapies, which are targeted at metabolism.With approximately one out of six American men being diagnosed and nearly a quarter of a million new cases expected this year, prostate cancer is the most common malignancy among men in the U.S.
Novel neural crest system developed in zebrafish
3/04/2014
Researchers at the Massachusetts General Hospital (MGH)/Harvard Medical School, Drs. Beste Kinikoglu and Yawei Kong, led by Dr. Eric C. Liao, cultured and characterized for the first time multipotent neural crest cells isolated from zebrafish embryos. This important study is reported in the journal Experimental Biology and Medicine.
Mechanisms cancer cells use to establish metastatic brain tumors
3/04/2014
New research from Memorial Sloan Kettering provides fresh insight into the biologic mechanisms that individual cancer cells use to metastasize to the brain. Published in the journal Cell, the study found that tumor cells that reach the brain - and successfully grow into new tumors - hug capillaries and express specific proteins that overcome the brain's natural defense against metastatic invasion.
Researchers making treatment of rare blood disorder more affordable and effective
3/04/2014
A University of Pennsylvania research team has defined a possible new way to fight a disease that is currently treatable only with the most expensive drug available for sale in the United States.
Fighting cancer with light-activated drug delivery by nanoparticle
3/03/2014
A new type of treatment called "light-activated drug delivery" is showing promise as a way to give doctors control over precisely where and when drugs are delivered inside the patient's body. Now, researchers have developed a light-activated way to target cancer cells without hurting healthy tissue by using drug-carrying nanoparticles.